Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-26 @ 2:31 AM
Study NCT ID:
NCT06559202
Status:
COMPLETED
Last Update Posted:
2024-08-19
First Post:
2024-08-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Inguinal and Axillary LN Size Distribution
Sponsor:
Gachon University Gil Medical Center
Organization:
Study Overview
Official Title:
Evaluation of Inguinal and Axillary Lymph Node Size Distribution for Safe Intralymphatic Injection
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Recently, intralymphatic allergen-specific immunotherapy (ILIT) showed promising treatment outcomes for allergic rhinoconjunctivitis. However, the normal size distribution of superficial lymph nodes (LNs) on the trunk that are potential target LNs for ILIT has not been evaluated.
The objective of this study is to investigate the distribution of LN size in inguinal and axillary area.
The objective of this study is to investigate the distribution of LN size in inguinal and axillary area.
Detailed Description:
In this study, the long-axis diameters of the largest LNs in the inguinal and axillary areas were retrospectively measured in subjects who underwent chest and abdominopelvic computed tomography on the same day for health screening purposes from September 2022 to November 2022.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: